< Back to
< Back to all News
Elizabeth M. Hagerman Named Vice President for Rose-Hulman Ventures
May 4, 2012
Rose-Hulman Institute of Technology alumna Elizabeth M.
Hagerman, Ph.D., is returning to her alma mater to serve as Vice
President for Rose-Hulman Ventures, the institute's successful
innovation space that has spawned careers and entrepreneurial
enterprises throughout Indiana. She will report to Interim
President Rob Coons in a cabinet-level position that officially
begins on July 1.
Hagerman has a wealth of experience in business development,
business assessment and emerging technology evaluation through
leadership roles at Baxter Healthcare in Los Angeles. Baxter
Healthcare is a subsidiary of Illinois-based Baxter International
Inc., a worldwide leader patient care products. Hagerman most
recently led the global integration of a Baxter Biosurgery product
acquisition and licensing. She also has worked with Baxter
Biosurgery's Business Development office to provide scientific
assessment of more than 300 acquisition targets, including the
addition of a $330-million company.
While at Baxter, Hagerman has also worked with research and
development and marketing teams in the United States and Austria to
advance product development, coordinated academic research with
Baxter Biosurgery products, managed strategic planning for next
generation product launches and brand development, and developed
orthopedic sales training materials.
"Elizabeth has been an intrapreneur who can empathize with
entrepreneurs and engineers," stated Coons. "She has a passion for
education and experience with tech-transfer issues. She brings to
Rose-Hulman Ventures valuable experience and skill in business
development and strategic assessment of emerging technology. With
her expertise in working with technology and financial decision
makers, she can be a catalyst to build even more learning
opportunities for our students."
Hagerman earned a bachelor's degree in chemical engineering from
Rose-Hulman in 2000 before receiving master's and Ph.D. degrees
from UCLA in biomedical engineering, with a focus on orthopedic
biomaterials. She is an expert on tissue engineering, cell
adhesion, bone regeneration and tissue biomineralization, and has
two patent applications filed.
Throughout her academic and professional career, Hagerman has
been associated with Rose-Hulman. She received the Distinguished
Young Alumni Award in 2008, and has been a member of the Board of
Trustees since 2009. She will relinquish her board seat on June
"I'm looking forward to building relationships that help propel
the entrepreneurial experiences of Rose-Hulman students to the next
level. The depth and creativity of academia, combined with
expertise and culture of business, provide an exciting platform for
emerging ideas," said Hagerman.
Over the past 12 years Rose-Hulman Ventures has developed a
one-of-a-kind, higher education-business relationship model that
bridges the gap between research and the marketplace. At
Rose-Hulman Ventures, creative-thinking interns design innovative
products; build and test first-ever, functional prototypes; and
help move concepts to solve problems in a variety of real-world
engineering areas. This relationship drives value for clients who
tap into the nation's brightest engineering students; enhances the
education of many Rose-Hulman undergraduates; and has altered the
career paths of several alumni.
"Rose-Hulman Ventures has become an important differentiator for
Rose-Hulman," added Coons. "It has put on full display an important
long-standing core value of a Rose-Hulman education -- learning
engineering by doing engineering that is project-based, hands-on,
real-world and theory-into-practice. It is this brand of education
that leads employers of our graduates to affirm that our students
'hit the ground running.'"
This innovative enterprise is located in a 35,000-square-foot
facility on 180 acres in a Certified Technology Park on the
Institute's South Campus.